US HB2503 | 2017-2018 | 115th Congress
Status
Sponsorship: Slight Partisan Bill (Republican 2-1)
Status: Introduced on May 17 2017 - 25% progression, died in committee
Action: 2017-05-30 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 17 2017 - 25% progression, died in committee
Action: 2017-05-30 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
AIM Act of 2017 Accelerating Innovation in Medicine Act of 2017 This bill requires the Centers for Medicare & Medicaid Services (CMS) to develop, maintain, and make publicly available a list of medical devices that shall be voluntarily excluded from payment under the Medicare program. A Medicare beneficiary who consents to receive such a medical device shall be responsible for payment for the device. A manufacturer seeking to have a medical device included in the list must submit a request for inclusion to the CMS, in accordance with specified timelines. As a condition for a device's continued inclusion on the list, a manufacturer must provide the CMS with data on clinical studies completed with respect to the device.
Title
AIM Act of 2017 Accelerating Innovation in Medicine Act of 2017
Sponsors
| Rep. Erik Paulsen [R-MN] | Rep. Ron Kind [D-WI] | Rep. Mimi Walters [R-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2017-05-30 | House | Referred to the Subcommittee on Health. |
| 2017-05-19 | House | Referred to the Subcommittee on Health. |
| 2017-05-17 | House | Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2017-05-17 | House | Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2017-05-17 | House | Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2017-05-17 | House | Introduced in House |
Subjects
Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Government information and archives
Health
Health care coverage and access
Health information and medical records
Health technology, devices, supplies
Medicare
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Government information and archives
Health
Health care coverage and access
Health information and medical records
Health technology, devices, supplies
Medicare
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/115th-congress/house-bill/2503/all-info |
| Text | https://www.congress.gov/115/bills/hr2503/BILLS-115hr2503ih.pdf |
